Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
10.1002/trc2.12114 257 VuT
document neurologic and vascular findings
Castillo PE, Schoch S, Schmitz F, Sudhof TC, Malenka RC (2002)
B., Yogesh Kumar K., et al., Synthesis, Molecular Docking, Enzyme Inhibition and Antioxidant Potential of New 1HBenzo[d]Imidazole5Carboxamide Derivatives, Journal of Molecular Structure 1302 (2024): 137521, 10.1016/j.molstruc.2024.137521
3d), as did treatment with other TS-targeted antifolates pemetrexed and methotrexate in colon (Extended Data Fig
KEY FEATURES High-purity GHK-Cu research peptide 50mg lyophilised powder per vial HPLC-MS verified purity (99.76%) Manufactured in accredited laboratories Sterile, tamper-evident vial suitable for laboratory handling Fast, discreet Australia-wide shipping SPECIFICATIONS Product Name GHK-Cu Peptide Grade Research Grade Quantity 50mg per vial Form Lyophilised powder Purity 99.76% (HPLC-MS tested) Appearance White/off-white lyophilised powder Storage Conditions Cool, dry environment
US$ 27.78
US$ 26.29
US$ 29.22
US$ 21.15
US$ 29.79
US$ 29.04
US$ 20.64
US$ 27.22
US$ 20.92
